Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 3
2007 3
2008 1
2009 2
2010 3
2011 6
2012 4
2013 7
2014 6
2015 4
2016 5
2017 2
2018 8
2019 11
2020 13
2021 14
2022 17
2023 18
2024 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Cabozantinib in progressive medullary thyroid cancer.
Elisei R, Schlumberger MJ, Müller SP, Schöffski P, Brose MS, Shah MH, Licitra L, Jarzab B, Medvedev V, Kreissl MC, Niederle B, Cohen EE, Wirth LJ, Ali H, Hessel C, Yaron Y, Ball D, Nelkin B, Sherman SI. Elisei R, et al. Among authors: kreissl mc. J Clin Oncol. 2013 Oct 10;31(29):3639-46. doi: 10.1200/JCO.2012.48.4659. Epub 2013 Sep 3. J Clin Oncol. 2013. PMID: 24002501 Free PMC article. Clinical Trial.
Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer.
Petranović Ovčariček P, Campenni A, de Keizer B, Deandreis D, Kreissl MC, Vrachimis A, Tuncel M, Giovanella L. Petranović Ovčariček P, et al. Among authors: kreissl mc. Cancers (Basel). 2023 Aug 27;15(17):4290. doi: 10.3390/cancers15174290. Cancers (Basel). 2023. PMID: 37686566 Free PMC article. Review.
Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma.
Schlumberger M, Elisei R, Müller S, Schöffski P, Brose M, Shah M, Licitra L, Krajewska J, Kreissl MC, Niederle B, Cohen EEW, Wirth L, Ali H, Clary DO, Yaron Y, Mangeshkar M, Ball D, Nelkin B, Sherman S. Schlumberger M, et al. Among authors: kreissl mc. Ann Oncol. 2017 Nov 1;28(11):2813-2819. doi: 10.1093/annonc/mdx479. Ann Oncol. 2017. PMID: 29045520 Free PMC article. Clinical Trial.
[Therapy concepts for thyroid carcinoma].
Eilsberger F, Kreissl MC, Luster M, Pfestroff A. Eilsberger F, et al. Among authors: kreissl mc. Laryngorhinootologie. 2023 Jul;102(7):488-495. doi: 10.1055/a-1861-7379. Epub 2023 Apr 3. Laryngorhinootologie. 2023. PMID: 37011888 German.
[Therapy concepts for thyroid carcinoma].
Eilsberger F, Kreissl MC, Luster M, Pfestroff A. Eilsberger F, et al. Among authors: kreissl mc. Nuklearmedizin. 2022 Jun;61(3):223-230. doi: 10.1055/a-1650-9762. Epub 2022 Jun 3. Nuklearmedizin. 2022. PMID: 34644802 German.
The European Association of Nuclear Medicine (EANM)'s Response to the 2023 European Thyroid Association (ETA) clinical practice guidelines for thyroid nodule management and nuclear medicine: a deliberate oversight?
Kreissl MC, Ovčariček PP, Campenni A, Vrachimis A, Tuncel M, Giovanella L. Kreissl MC, et al. Eur J Nucl Med Mol Imaging. 2024 May;51(6):1678-1681. doi: 10.1007/s00259-023-06571-z. Eur J Nucl Med Mol Imaging. 2024. PMID: 38226985 Free PMC article. No abstract available.
Apparently Benign 131I Adrenal Uptake.
Travaglio Morales D, Kreissl MC, Fischer F, Heinzel A. Travaglio Morales D, et al. Among authors: kreissl mc. Clin Nucl Med. 2024 Aug 2. doi: 10.1097/RLU.0000000000005398. Online ahead of print. Clin Nucl Med. 2024. PMID: 39093045
The Treatment of Well-Differentiated Thyroid Carcinoma.
Paschke R, Lincke T, Müller SP, Kreissl MC, Dralle H, Fassnacht M. Paschke R, et al. Among authors: kreissl mc. Dtsch Arztebl Int. 2015 Jun 26;112(26):452-8. doi: 10.3238/arztebl.2015.0452. Dtsch Arztebl Int. 2015. PMID: 26205749 Free PMC article. Review.
120 results